Diphosphonates inhibit human osteoblast secretion and proliferation
- 1 February 1989
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 38 (2) , 184-187
- https://doi.org/10.1016/0026-0495(89)90260-6
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENTThe Lancet, 1987
- Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitroJournal of Endocrinology, 1985
- Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoidsMetabolic Bone Disease and Related Research, 1984
- Increase in alkaline phosphatase activity in calvaria cells cultured with diphosphonatesBiochemical Journal, 1979
- Diphosphonate Therapy of Paget's Disease of BoneJournal of Clinical Endocrinology & Metabolism, 1977
- Myositis ossificans progressiva. Clinical features of eight patients and their response to treatmentThe Journal of Bone and Joint Surgery. British volume, 1976
- Influence of Disodium Etidronate on Clinical and Laboratory Manifestations of Paget's Disease of Bone (Osteitis Deformans)New England Journal of Medicine, 1973
- Effect of diphosphonates and calcitonin on the chemistry and quantitative histology of rat boneCalcified Tissue International, 1973
- DIPHOSPHONATES AND PAGET'S DISEASE OF BONEThe Lancet, 1971
- The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatitein vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised ratsCalcified Tissue International, 1970